Anzalone Christopher Richard

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 51% 68% 82%
Transactions
37 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Anzalone Christopher Richard's trades of Arrowhead Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-05 2026-01-02
PlS Planned sale
95,270 +2.0%
265.11
US$3,950,532 		95,270 +2.0% 265.11 US$3,950,532
2026-01-05 2026-01-02
PlS Planned sale
33,384 +21.3%
120.32
US$3,174,339 		33,384 +21.3% 120.32 US$3,174,339
2026-01-02 2026-01-02
PrS Proposed sale
75,129
206.40
US$4,919,481 		75,129 206.40 US$4,919,481
2025-12-30 2025-12-29
PlS Planned sale
16,545 -0.4%
68.69
US$1,136,476 		16,545 -0.4% 68.69 US$1,136,476
2025-12-30 2025-12-29
PlS Planned sale
35,181 -0.9%
69.33
US$2,439,099 		35,181 -0.9% 69.33 US$2,439,099
2025-12-29 2025-12-29
PrS Proposed sale
51,726
69.13
US$3,575,575 		51,726 69.13 US$3,575,575
2025-12-23 2025-12-22
PlS Planned sale
2,574 -0.1%
68.85
US$177,220 		2,574 -0.1% 68.85 US$177,220
2025-12-23 2025-12-22
PlS Planned sale
10,012 -0.3%
68.33
US$684,120 		10,012 -0.3% 68.33 US$684,120
2025-12-22 2025-12-22
PrS Proposed sale
12,586
68.43
US$861,319 		12,586 68.43 US$861,319
2025-12-23 2025-12-19
PlS Planned sale
1,319 -0.0%
68.48
US$90,325 		1,319 -0.0% 68.48 US$90,325
2025-12-23 2025-12-19
PlS Planned sale
8,147 -0.2%
68.01
US$554,077 		8,147 -0.2% 68.01 US$554,077
2025-12-23 2025-12-19
PlS Planned sale
3,979 -0.1%
66.67
US$265,280 		3,979 -0.1% 66.67 US$265,280
2025-12-19 2025-12-19
PrS Proposed sale
13,445
67.66
US$909,632 		13,445 67.66 US$909,632
2025-12-19 2025-12-17
S Sale
1,981 -0.1%
66.30
US$131,340 		1,981 -0.1% 66.30 US$131,340
2025-12-19 2025-12-17
S Sale
982 -0.0%
65.53
US$64,350 		982 -0.0% 65.53 US$64,350
2025-12-19 2025-12-17
S Sale
35,750 -0.9%
64.51
US$2,306,232 		35,750 -0.9% 64.51 US$2,306,232
2025-12-19 2025-12-17
S Sale
46,287 -1.2%
63.55
US$2,941,539 		46,287 -1.2% 63.55 US$2,941,539
2025-12-17 2025-12-17
PrS Proposed sale
85,000
64.04
US$5,443,253 		85,000 64.04 US$5,443,253
2025-12-16 2025-12-16
PrS Proposed sale
54,298
62.58
US$3,398,142 		54,298 62.58 US$3,398,142
2025-12-16 2025-12-16
S Sale
3,221 -0.1%
67.87
US$218,609 		3,221 -0.1% 67.87 US$218,609
2025-12-16 2025-12-16
S Sale
166 -0.0%
66.77
US$11,084 		166 -0.0% 66.77 US$11,084
2025-12-16 2025-12-16
S Sale
1,300 -0.0%
65.77
US$85,501 		1,300 -0.0% 65.77 US$85,501
2025-12-16 2025-12-16
S Sale
1,000 -0.0%
64.96
US$64,960 		1,000 -0.0% 64.96 US$64,960
2025-12-16 2025-12-16
S Sale
6,661 -0.2%
64.29
US$428,236 		6,661 -0.2% 64.29 US$428,236
2025-12-16 2025-12-16
S Sale
8,476 -0.2%
62.94
US$533,479 		8,476 -0.2% 62.94 US$533,479
2025-12-16 2025-12-16
S Sale
14,095 -0.4%
62.12
US$875,581 		14,095 -0.4% 62.12 US$875,581
2025-12-16 2025-12-16
S Sale
10,963 -0.3%
61.25
US$671,484 		10,963 -0.3% 61.25 US$671,484
2025-12-16 2025-12-16
S Sale
8,416 -0.2%
60.51
US$509,252 		8,416 -0.2% 60.51 US$509,252
2025-12-16 2025-12-15
S Sale
8,147 -0.2%
69.96
US$569,964 		8,147 -0.2% 69.96 US$569,964
2025-12-16 2025-12-15
S Sale
21,321 -0.5%
69.28
US$1,477,119 		21,321 -0.5% 69.28 US$1,477,119
2025-12-16 2025-12-15
S Sale
100,532 -2.5%
68.67
US$6,903,532 		100,532 -2.5% 68.67 US$6,903,532
2025-12-15 2025-12-15
PrS Proposed sale
130,000
68.85
US$8,950,580 		130,000 68.85 US$8,950,580
2025-04-11 2025-04-11
PrS Proposed sale
50,800
11.49
US$583,751 		50,800 11.49 US$583,751
2025-04-11 2025-04-11
S Sale
50,800 -1.3%
11.49
US$583,692 		50,800 -1.3% 11.49 US$583,692
2025-04-11 2025-04-10
S Sale
50,000 -1.2%
10.87
US$543,500 		50,000 -1.2% 10.87 US$543,500
2025-04-10 2025-04-10
PrS Proposed sale
50,000
10.86
US$543,215 		50,000 10.86 US$543,215
2025-04-11 2025-04-09
S Sale
1,617 -0.0%
11.76
US$19,016 		1,617 -0.0% 11.76 US$19,016
2025-04-11 2025-04-09
S Sale
3,400 -0.1%
10.75
US$36,550 		3,400 -0.1% 10.75 US$36,550
2025-04-11 2025-04-09
S Sale
35,305 -0.9%
9.93
US$350,579 		35,305 -0.9% 9.93 US$350,579
2025-04-09 2025-04-09
PrS Proposed sale
40,322
10.07
US$406,057 		40,322 10.07 US$406,057
2025-03-17 2025-03-13
S Sale
51,425 -1.3%
15.07
US$774,975 		51,425 -1.3% 15.07 US$774,975
2025-03-13 2025-03-13
PrS Proposed sale
51,425
15.07
US$774,785 		51,425 15.07 US$774,785
2025-03-05 2025-03-04
PlS Planned sale
133,333 -3.4%
17.02
US$2,269,328 		133,333 -3.4% 17.02 US$2,269,328
2025-03-04 2025-03-04
PrS Proposed sale
133,333
17.02
US$2,268,742 		133,333 17.02 US$2,268,742
2025-03-05 2025-03-03
PlS Planned sale
166,667 -4.1%
18.03
US$3,005,006 		166,667 -4.1% 18.03 US$3,005,006